Colchicine | Zee News

Advertisement

Colchicine News

Drugs Controller General of India (DCGI)

12 Jun 2021

CSIR-Laxai gets DCGI nod for clinical trials of Colchicine on COVID patients

DCGI has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct a clinical trial of Colchicine on COVID-19 patients. The partner CSIR institutes in this important clinical trial are the CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu.

31 May 2021

This cheap, oral anti-inflammatory drug can reduce COVID severity

Colchicine could be used to reduce the risk of complications for some patients with COVID-19 The results showed that of 4,159 patients with COVID, the primary endpoint -- that is the composite of death or hospitalisation -- occurred in 4.6 per cent of patients in the colchicine group compared to 6.0 per cent in the placebo group

Loading...

NEWS ON ONE CLICK